| pubmed-article:19789232 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19789232 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:19789232 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
| pubmed-article:19789232 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
| pubmed-article:19789232 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:19789232 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
| pubmed-article:19789232 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:19789232 | lifeskim:mentions | umls-concept:C0291216 | lld:lifeskim |
| pubmed-article:19789232 | lifeskim:mentions | umls-concept:C1613998 | lld:lifeskim |
| pubmed-article:19789232 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19789232 | pubmed:dateCreated | 2009-12-2 | lld:pubmed |
| pubmed-article:19789232 | pubmed:abstractText | To retrospectively compare, in a multiobserver study, double-contrast-material (sequential administration of ferucarbotran and gadobutrol) magnetic resonance (MR) imaging with single-contrast-material ferucarbotran-enhanced and dynamic postferucarbotran gadobutrol-enhanced MR imaging for the detection and characterization of benign and malignant focal liver lesions. | lld:pubmed |
| pubmed-article:19789232 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19789232 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19789232 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19789232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19789232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19789232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19789232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19789232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19789232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19789232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19789232 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19789232 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19789232 | pubmed:issn | 1527-1315 | lld:pubmed |
| pubmed-article:19789232 | pubmed:author | pubmed-author:SeifertBurkha... | lld:pubmed |
| pubmed-article:19789232 | pubmed:author | pubmed-author:WillmannJürge... | lld:pubmed |
| pubmed-article:19789232 | pubmed:author | pubmed-author:WeishauptDomi... | lld:pubmed |
| pubmed-article:19789232 | pubmed:author | pubmed-author:LutzAmelie... | lld:pubmed |
| pubmed-article:19789232 | pubmed:author | pubmed-author:BologNicolaeN | lld:pubmed |
| pubmed-article:19789232 | pubmed:author | pubmed-author:HeilmaierChri... | lld:pubmed |
| pubmed-article:19789232 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19789232 | pubmed:volume | 253 | lld:pubmed |
| pubmed-article:19789232 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19789232 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19789232 | pubmed:pagination | 724-33 | lld:pubmed |
| pubmed-article:19789232 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:meshHeading | pubmed-meshheading:19789232... | lld:pubmed |
| pubmed-article:19789232 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19789232 | pubmed:articleTitle | Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. | lld:pubmed |
| pubmed-article:19789232 | pubmed:affiliation | Institute of Diagnostic Radiology, University Hospital Zurich, Zurich, Switzerland. | lld:pubmed |
| pubmed-article:19789232 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19789232 | pubmed:publicationType | Comparative Study | lld:pubmed |
